fMRI exploration of a biased agonist of 5-HT1A receptors to treat levodopa-induced dyskinesia in hemiparkinsonian rats

被引：0
作者：
Chaib, S. [1 ]
Vidal, B. [1 ]
Newman-Tancredi, A. [2 ]
Levigoureux, E. [3 ]
Zimmer, L. [1 ]
机构：
[1] Univ Claude Bernard Lyon 1, Univ Lyon, Lyon Neurosci Res Ctr, CNRS,UMR 5292,INSERM,U1028, Lyon, France
[2] Neurolixis Inc, Castres, France
[3] Hosp Civils Lyon, Lyon, France
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2022年 / 36卷
关键词：
5-HT1A receptors; biased agonist; fMRI; functional connectivity; L-DOPA induced dyskinesia; DOPA-INDUCED DYSKINESIA;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
CO-024
引用
收藏
页码：22 / 22
页数：1
相关论文
共 31 条
  • [21] 5-HT1A receptor activation improves anti-cataleptic effects of levodopa in 6-hydroxydopamine-lesioned rats
    Mahmoudi, J.
    Nayebi, Mohajjel A.
    Samini, M.
    Reyhani-Rad, S.
    Babapour, V
    DARU-JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 19 (05) : 338 - 343
  • [22] Role of the primary motor cortex in L-DOPA-induced dyskinesia and its modulation by 5-HT1A receptor stimulation
    Ostock, Corinne Y.
    Dupre, Kristin B.
    Jaunarajs, Karen L. Eskow
    Walters, Hannah
    George, Jessica
    Krolewski, David
    Walker, Paul D.
    Bishop, Christopher
    NEUROPHARMACOLOGY, 2011, 61 (04) : 753 - 760
  • [23] BIASED DOPAMINE D3R AGONIST NORMALIZES D1R-D3R FUNCTION TO ATTENUATE LEVODOPA INDUCED DYSKINESIA
    Kortagere, Sandhya
    Das, Sanjay
    Nepal, Binod
    Hicks, Alexandra
    Ferre, Sergi
    NEUROPSYCHOPHARMACOLOGY, 2024, 49 : 348 - 348
  • [24] Transcriptome Sequencing Reveal That Rno-Rsf1_0012 Participates in Levodopa-Induced Dyskinesia in Parkinson's Disease Rats via Binding to Rno-mir-298-5p
    Han, Chun-Lei
    Wang, Qiao
    Liu, Chong
    Li, Zhi-Bao
    Du, Ting-Ting
    Sui, Yun-Peng
    Zhang, Xin
    Zhang, Jian-Guo
    Xiao, Yi-Lei
    Cai, Guo-En
    Meng, Fan-Gang
    BRAIN SCIENCES, 2022, 12 (09)
  • [25] NLX-112, a highly selective 5-HT1A receptor agonist: Effects on body temperature and plasma corticosterone levels in rats
    Newman-Tancredi, A.
    Depoortere, R.
    Carilla-Durand, E.
    Tarayre, J. P.
    Kleven, M.
    Koek, W.
    Bardin, L.
    Varney, M. A.
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2018, 165 : 56 - 62
  • [26] The abnormal activation of D1R/Shp-2 complex involved in levodopa-induced dyskinesia in 6-hydroxydopamine-lesioned Parkinson's rats
    Wu, Na
    Wan, Ying
    Song, Lu
    Qi, Chen
    Liu, Zhenguo
    Gan, Jing
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2018, 14 : 1779 - 1786
  • [27] BDNF overexpression exacerbates D1R agonist-induced dyskinesia in hemiparkinsonian rats via D1R-D3R heteromers formation
    Corsi, S.
    Scheggi, S.
    Rossi, F.
    Fanni, S.
    Tronci, E.
    Congiu, L.
    Vargiu, R.
    Gambarana, C.
    Munoz, A.
    Stancampiano, R.
    Bjorklund, A.
    Carta, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2020, 31 : S24 - S25
  • [28] Receptor-heteromer mediated regulation of endocannabinoid signaling in activated microglia. Role of CB1 and CB2 receptors and relevance for Alzheimer's disease and levodopa-induced dyskinesia
    Navarro, Gemma
    Borroto-Escuela, Dasiel
    Angelats, Edgar
    Etayo, Inigo
    Reyes-Resina, Irene
    Pulido-Salgado, Marta
    Rodriguez-Perez, Ana I.
    Canela, Enric I.
    Saura, Josep
    Luis Lanciego, Jose
    Luis Labandeira-Garcia, Jose
    Saura, Carlos A.
    Fuxe, Kjell
    Franco, Rafael
    BRAIN BEHAVIOR AND IMMUNITY, 2018, 67 : 139 - 151
  • [29] The novel 5-HT1A, receptor agonist, NLX-112 reduces L-DOPA-induced abnormal involuntary movements in rat: A chronic administration study with microdialysis measurements
    McCreary, Andrew C.
    Varney, Mark A.
    Newman-Tancredi, Adrian
    NEUROPHARMACOLOGY, 2016, 105 : 651 - 660
  • [30] Role of dopamine D3 and serotonin 5-HT1A receptors in L-DOPA-induced dyskinesias and effects of sarizotan in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease
    Gerlach, Manfred
    Bartoszyk, Gerd D.
    Riederer, Peter
    Dean, Olivia
    van den Buuse, Maarten
    JOURNAL OF NEURAL TRANSMISSION, 2011, 118 (12) : 1733 - 1742
1234